Kasper C - Search Results

1

Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells.

Dürig J, Rosenthal C, Elmaagacli A, Heyworth C, Halfmeyer K, Kasper C, Novotny J, Dührsen U. Dürig J, et al. Among authors: kasper c. Leukemia. 2000 Sep;14(9):1652-60. doi: 10.1038/sj.leu.2401875. Leukemia. 2000. PMID: 10995013

2

Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alpha.

Dürig J, Testa NG, Lord BI, Kasper C, Chang J, Telford N, Dexter TM, Heyworth CM. Dürig J, et al. Among authors: kasper c. Leukemia. 1999 Dec;13(12):2012-22. doi: 10.1038/sj.leu.2401610. Leukemia. 1999. PMID: 10602423

3

Interferon alpha (IFN) treatment of bone marrow stroma inhibits haematopoesis.

Kasper C, Lübking A, Beelen DW, Dührsen U. Kasper C, et al. Leuk Res. 2004 Nov;28(11):1217-20. doi: 10.1016/j.leukres.2004.03.012. Leuk Res. 2004. PMID: 15380348

4

Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma.

Dürig J, de Wynter EA, Kasper C, Cross MA, Chang J, Testa NG, Heyworth CM. Dürig J, et al. Among authors: kasper c. Blood. 1998 Nov 1;92(9):3073-81. Blood. 1998. PMID: 9787141 Free article.

5

Content of long-term culture-initiating cells, clonogenic progenitors and CD34 cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma.

Kasper C, Ryder WD, Dürig J, Nagesh K, Scarfee JH, Beelen DW, Schaefer UW, Chang J, Testa NG. Kasper C, et al. Br J Haematol. 1999 Feb;104(2):374-81. doi: 10.1046/j.1365-2141.1999.01152.x. Br J Haematol. 1999. PMID: 10050722 Free article.

6

Recombinant human megakaryocyte growth and development factor (MGDF) increases the numbers of megakaryocyte progenitor cells to normal values in long-term bone marrow cultures of patients with AML in first remission.

Kasper C, Schwarzer A, De Wynter EA, Chang J, Dexter TM, Ryder D, Testa NG. Kasper C, et al. Leukemia. 1998 Jun;12(6):907-11. doi: 10.1038/sj.leu.2401025. Leukemia. 1998. PMID: 9639419

7

Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.

Müller-Beissenhirtz H, Kasper C, Nückel H, Dührsen U. Müller-Beissenhirtz H, et al. Among authors: kasper c. Ann Hematol. 2005 Nov;84(12):796-801. doi: 10.1007/s00277-005-1082-9. Epub 2005 Nov 12. Ann Hematol. 2005. PMID: 16041531 Clinical Trial.

8

Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma.

Fosså A, Muer M, Kasper C, Welt A, Seeber S, Nowrousian MR. Fosså A, et al. Among authors: kasper c. Leukemia. 1998 Mar;12(3):422-6. doi: 10.1038/sj.leu.2400945. Leukemia. 1998. PMID: 9529138 Clinical Trial.

9

BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemia.

Fosså A, Siebert R, Kasper C, Becher R, Opalka B, Thiel E, Seeber S, Nowrousian MR. Fosså A, et al. Among authors: kasper c. Br J Haematol. 1996 May;93(2):403-5. Br J Haematol. 1996. PMID: 8639438

10

In vitro effects of recombinant human megakaryocyte growth and development factor on primary human tumour colony growth.

Lang SH, West CM, Jones L, Brooks B, Kasper C, deWynter E, Testa NG. Lang SH, et al. Among authors: kasper c. Oncology. 1997 Mar-Apr;54(2):141-5. doi: 10.1159/000227678. Oncology. 1997. PMID: 9075786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters